Literature DB >> 8674509

Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis.

J B Allen1, M C McGahan, J B Ferrell, K B Adler, L N Fleisher.   

Abstract

Nitric oxide (NO) is a highly reactive radical which plays an integral role in physiological and pathophysiological processes. NO is produced endogenously in small amounts by a constitutive NO synthase (cNOS) as a regulator of vascular tone and neurotransmission. NO can also be produced in large amounts by an inducible NOS (iNOS) in response to endotoxin and cytokines, and has been reported to be a mediator of lipopolysaccharide (LPS)-induced uveitis in rats. The purpose of the present study was to investigate the effects of NOS inhibitors with different NOS isoform specificities in the rabbit model of endotoxin-induced ocular inflammation. LPS and/or inhibitors of NOS. NG-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (AG), were injected intravitreally and the eyes observed by slit lamp for 24 hr. Coinjection of LPS with L-NAME inhibited anterior inflammation in rabbits. Iridal hyperemia (IH) and aqueous flare (AF) were completely abolished in eight out of nine rabbits in a dose-dependent manner. In addition, total cell counts were significantly suppressed (7393 +/- 697 vs. 325 +/- 188, P < 0.05) and aqueous protein levels were reduced to near control levels (25 +/- 0.75 vs. 1.72 +/- 0.36, P < 0.05). Similar suppression was seen with AG (cell counts = 351 +/- 246 and proteins = 3.1 +/- 1.2). Administration of L-NAME 0.5 hr after LPS injection suppressed inflammation to a lesser extent than coinjection. In contrast, administration of L-NAME 6 hr after LPS injection was not inhibitory, and in fact significantly increased cellular infiltration. However, AG given 6 hr after LPS had a remarkably different effect, since it significantly decreased both protein extravasation and cellular infiltration into the aqueous humor. In fact, our results suggest that cNOS may play a greater role in the earlier stages of this developing inflammatory response. These results extend others' observations that NO is a key mediator in uveitis, that induction of iNOS plays a critical role in experimental uveitis, and suggest that NO has a complex role in the ocular inflammatory process. Inhibitors of NOS can abort the LPS-induced inflammatory response if administered early enough, but could potentially exacerbate an established inflammatory episode.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674509     DOI: 10.1006/exer.1996.0003

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

Review 1.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Determination of a No Observable Effect Level for Endotoxin Following a Single Intravitreal Administration to Cynomolgus Monkeys.

Authors:  Vladimir Bantseev; Paul E Miller; T Michael Nork; Carol A Rasmussen; Aija McKenzie; Brian J Christian; Helen Booler; Evan A Thackaberry
Journal:  J Ocul Pharmacol Ther       Date:  2019-04-09       Impact factor: 2.671

3.  Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU).

Authors:  Nalini S Bora; Jeong-Hyeon Sohn; Puran S Bora; Henry J Kaplan; Prasad Kulkarni
Journal:  Ocul Immunol Inflamm       Date:  2005 Apr-Jun       Impact factor: 3.070

4.  Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory response.

Authors:  Cristhian J Ildefonso; Henrique Jaime; Manas R Biswal; Shannon E Boye; Qiuhong Li; William W Hauswirth; Alfred S Lewin
Journal:  Mol Ther       Date:  2015-02-20       Impact factor: 11.454

Review 5.  Modulation of autoimmune diseases by nitric oxide.

Authors:  V K Singh; S Mehrotra; P Narayan; C M Pandey; S S Agarwal
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

6.  Mechanisms of TQ-6, a Novel Ruthenium-Derivative Compound, against Lipopolysaccharide-Induced In Vitro Macrophage Activation and Liver Injury in Experimental Mice: The Crucial Role of p38 MAPK and NF-κB Signaling.

Authors:  Chih-Hsuan Hsia; Marappan Velusamy; Thanasekaran Jayakumar; Yen-Jen Chen; Chih-Wei Hsia; Jie-Heng Tsai; Ruei-Dun Teng; Joen-Rong Sheu
Journal:  Cells       Date:  2018-11-19       Impact factor: 6.600

Review 7.  Nitric oxide and peroxynitrite production in ocular inflammation.

Authors:  J B Allen; T Keng; C Privalle
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.